Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma (Q61053563)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

diffuse large B-cell lymphoma

1 reference

inferred from title

author

Pierre-Julien Viailly

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Christiane Copie Bergman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Thierry Fest

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Thierry Lecroq

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Karen Leroy

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Sylvain Mareschal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Sydney Dubois

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Philippe Bertrand

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Elodie Bohers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Catherine Maingonnat

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Jean-Philippe Jaïs

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Bruno Tesson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Philippe Ruminy

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Pauline Peyrouze

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Thierry Jo Molina

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Corinne Haioun

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Gilles Salles

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Hervé Tilly

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Fabrice Jardin

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

26 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

Genes, Chromosomes and Cancer

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

251-267

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

The kynurenine pathway in brain tumor pathogenesis.

1 March 2020

cites work

1 reference

7 January 2021

Signatures of mutational processes in human cancer

1 reference

7 January 2021

Detection of novel germline mutations for breast cancer in non-BRCA1/2 families

1 reference

7 January 2021

Inferring copy number and genotype in tumour exome data

1 reference

7 January 2021

Interleukin-13 stimulation of the mediastinal B-cell lymphoma cell line Karpas-1106P induces a phenotype resembling the Hodgkin lymphoma cell line L1236.

1 reference

7 January 2021

Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma: relationship with tumor aggressiveness

1 reference

7 January 2021

Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era.

1 reference

7 January 2021

Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity

1 reference

7 January 2021

Mutational analysis of primary central nervous system lymphoma

1 reference

7 January 2021

BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma

1 reference

7 January 2021

Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma

1 reference

7 January 2021

Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma

1 reference

7 January 2021

1 reference

7 January 2021

Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.

1 reference

7 January 2021

MuSiC: identifying mutational significance in cancer genomes

1 reference

7 January 2021

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.

1 reference

7 January 2021

p55PIK transcriptionally activated by MZF1 promotes colorectal cancer cell proliferation

1 reference

7 January 2021

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

1 reference

7 January 2021

Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells

1 reference

7 January 2021

KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.

1 reference

7 January 2021

MYD88 (L265P) mutation is an independent prognostic factor for outcome in patients with diffuse large B-cell lymphoma

1 reference

7 January 2021

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.

1 reference

7 January 2021

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

1 reference

7 January 2021

The sphingosine 1-phosphate receptor S1P₂ maintains the homeostasis of germinal center B cells and promotes niche confinement

1 reference

7 January 2021

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma

1 reference

7 January 2021

Hallmarks of Cancer: The Next Generation

1 reference

7 January 2021

Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.

1 reference

7 January 2021

Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)

1 reference

7 January 2021

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

1 reference

7 January 2021

Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases

1 reference

7 January 2021

Discovery and saturation analysis of cancer genes across 21 tumour types

1 reference

7 January 2021

Characterization of the nuclear import and export functions of Ikappa B(epsilon).

1 reference

7 January 2021

Interleukin-18-mediated interferon-gamma secretion is regulated by thymosin beta 4 in human NK cells

1 reference

7 January 2021

1 reference

7 January 2021

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

1 reference

7 January 2021

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program

1 reference

7 January 2021

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

1 reference

7 January 2021

Inositol 1,3,4,5-tetrakisphosphate controls proapoptotic Bim gene expression and survival in B cells

1 reference

7 January 2021

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

1 reference

7 January 2021

Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line

1 reference

7 January 2021

Production of Ins(1,3,4,5)P4 mediated by the kinase Itpkb inhibits store-operated calcium channels and regulates B cell selection and activation.

1 reference

7 January 2021

Evaluation of genomic high-throughput sequencing data generated on Illumina HiSeq and genome analyzer systems

1 reference

7 January 2021

Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/

1 reference

7 January 2021

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

1 reference

7 January 2021

Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing

1 reference

7 January 2021

Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma

1 reference

7 January 2021

Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP

1 reference

7 January 2021

Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma

1 reference

7 January 2021

Analysis of the coding genome of diffuse large B-cell lymphoma

1 reference

7 January 2021

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

1 reference

7 January 2021

Thymosin β4 induces invasion and migration of human colorectal cancer cells through the ILK/AKT/β-catenin signaling pathway

1 reference

7 January 2021

Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte development

1 reference

7 January 2021

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

1 reference

7 January 2021

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.

1 reference

7 January 2021

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.

1 reference

7 January 2021

Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.

1 reference

7 January 2021

Functional analysis of sucrase-isomaltase mutations from chronic lymphocytic leukemia patients

1 reference

7 January 2021

Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

1 reference

7 January 2021

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

1 reference

7 January 2021

Characterizing and measuring bias in sequence data

1 reference

7 January 2021

Cooperative epigenetic modulation by cancer amplicon genes

1 reference

7 January 2021

SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients

1 reference

7 January 2021

TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

1 reference

7 January 2021

Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity

1 reference

7 January 2021

The molecular pathogenesis of primary mediastinal large B-cell lymphoma

1 reference

7 January 2021

MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8.

1 reference

7 January 2021

Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export

1 reference

7 January 2021

Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large B-cell lymphoma: a review of the literature

1 reference

7 January 2021

Analysis of FOXO1 mutations in diffuse large B-cell lymphoma

1 reference

7 January 2021

Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma.

1 reference

7 January 2021

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia

1 reference

7 January 2021

Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1

1 reference

7 January 2021

PathScan: a tool for discerning mutational significance in groups of putative cancer genes

1 reference

7 January 2021

Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation

1 reference

7 January 2021

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

1 reference

7 January 2021

Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma

1 reference

7 January 2021

MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma

1 reference

7 January 2021

Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma

1 reference

7 January 2021

Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase.

1 reference

7 January 2021

Genetic heterogeneity of diffuse large B-cell lymphoma

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.22328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608593%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference